SC 13G
KINIKSA PHARMACEUTICALS, LTD.
- Filed
- February 14, 2019
- Accession Number
- 0000902664-19-001108
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →